Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Rochelle P. Walensky, M.D.

TitleProfessor of Medicine
InstitutionMassachusetts General Hospital
DepartmentMedicine
AddressMassachusetts General Hospital
General Medicine, 9th Floor
50 Staniford Street
Boston MA 02114
Phone617/724-3467
Fax617/726-2691

 Mentoring 
 completed student projects
Missed Opportunities: Refusal to Confirm Reactive HIV Rapid Tests in an Urban Emergency Department
Full Time/Year Long, 02/15/10 - 02/15/11

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Yazdanpanah Y, Perelman J, Dilorenzo MA, Alves J, Barros H, Mateus C, Pereira J, Mansinho K, Robine M, Park JE, Ross EL, Losina E, Walensky RP, Noubary F, Freedberg KA, Paltiel AD. Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness. PLoS One. 2013; 8(12):e84173.
    View in: PubMed
  2. Ciaranello AL, Morris BL, Walensky RP, Weinstein MC, Ayaya S, Doherty K, Leroy V, Hou T, Desmonde S, Lu Z, Noubary F, Patel K, Ramirez-Avila L, Losina E, Seage Iii GR, Freedberg KA. Validation and Calibration of a Computer Simulation Model of Pediatric HIV Infection. PLoS One. 2013; 8(12):e83389.
    View in: PubMed
  3. Kerry VB, Walensky RP, Tsai AC, Bergmark RW, Bergmark BA, Rouse C, Bangsberg DR. US medical specialty global health training and the global burden of disease. J Glob Health. 2013 Dec; 3(2):20406.
    View in: PubMed
  4. Govindasamy D, Kranzer K, van Schaik N, Noubary F, Wood R, Walensky RP, Freedberg KA, Bassett IV, Bekker LG. Linkage to HIV, TB and Non-Communicable Disease Care from a Mobile Testing Unit in Cape Town, South Africa. PLoS One. 2013; 8(11):e80017.
    View in: PubMed
  5. Hung KJ, Tsai AC, Johnson TR, Walensky RP, Bangsberg DR, Kerry VB. Scope of global health training in u.s. Obstetrics and gynecology residency programs. Obstet Gynecol. 2013 Nov; 122(5):1101-9.
    View in: PubMed
  6. Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel AD, Nakamura YM, Godbole SV, Panchia R, Sanne I, Weinstein MC, Losina E, Mayer KH, Chen YQ, Wang L, McCauley M, Gamble T, Seage GR, Cohen MS, Freedberg KA. Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med. 2013 Oct 31; 369(18):1715-25.
    View in: PubMed
  7. Hyle EP, Sax PE, Walensky RP. Potential savings by reduced CD4 monitoring in stable patients with HIV receiving antiretroviral therapy. JAMA Intern Med. 2013 Oct 14; 173(18):1746-8.
    View in: PubMed
  8. Walensky RP. Combination HIV prevention: the value and interpretation of mathematical models. Curr HIV/AIDS Rep. 2013 Sep; 10(3):195-8.
    View in: PubMed
  9. Bassett IV, Giddy J, Chaisson CE, Ross D, Bogart LM, Coleman SM, Govender T, Robine M, Erlwanger A, Freedberg KA, Katz JN, Walensky RP, Losina E. A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial. BMC Infect Dis. 2013; 13:390.
    View in: PubMed
  10. Hyle EP, Wood BR, Backman ES, Noubary F, Hwang J, Lu Z, Losina E, Walensky RP, Gandhi RT. High Frequency of Hypothalamic-Pituitary-Adrenal Axis Dysfunction After Local Corticosteroid Injection in HIV-Infected Patients on Protease Inhibitor Therapy. J Acquir Immune Defic Syndr. 2013 Aug 15; 63(5):602-8.
    View in: PubMed
  11. Andrews JR, Lawn SD, Dowdy DW, Walensky RP. Challenges in Evaluating the Cost-effectiveness of New Diagnostic Tests for HIV-Associated Tuberculosis. Clin Infect Dis. 2013 Oct; 57(7):1021-6.
    View in: PubMed
  12. Venkatesh KK, Becker JE, Kumarasamy N, Nakamura YM, Mayer KH, Losina E, Swaminathan S, Flanigan TP, Walensky RP, Freedberg KA. Clinical Impact and Cost-Effectiveness of Expanded Voluntary HIV Testing in India. PLoS One. 2013; 8(5):e64604.
    View in: PubMed
  13. Walensky RP, Paltiel AD, Schackman BR. Cost-effectiveness of generic antiretroviral therapy. Ann Intern Med. 2013 May 21; 158(10):776-7.
    View in: PubMed
  14. Regan S, Losina E, Chetty S, Giddy J, Walensky RP, Ross D, Holst H, Katz JN, Freedberg KA, Bassett IV. Factors Associated with Self-Reported Repeat HIV Testing after a Negative Result in Durban, South Africa. PLoS One. 2013; 8(4):e62362.
    View in: PubMed
  15. Shenoy ES, Kim J, Rosenberg ES, Cotter JA, Lee H, Walensky RP, Hooper DC. Discontinuation of Contact Precautions for Methicillin-Resistant Staphylococcus aureus: A Randomized Controlled Trial Comparing Passive and Active Screening With Culture and Polymerase Chain Reaction. Clin Infect Dis. 2013 Jul; 57(2):176-84.
    View in: PubMed
  16. Losina E, Daigle ME, Suter LG, Hunter DJ, Solomon DH, Walensky RP, Jordan JM, Burbine SA, Paltiel AD, Katz JN. Disease-modifying drugs for knee osteoarthritis: can they be cost-effective? Osteoarthritis Cartilage. 2013 May; 21(5):655-67.
    View in: PubMed
  17. Drain PK, Losina E, Parker G, Giddy J, Ross D, Katz JN, Coleman SM, Bogart LM, Freedberg KA, Walensky RP, Bassett IV. Risk Factors for Late-Stage HIV Disease Presentation at Initial HIV Diagnosis in Durban, South Africa. PLoS One. 2013; 8(1):e55305.
    View in: PubMed
  18. Walensky RP, Sax PE, Nakamura YM, Weinstein MC, Pei PP, Freedberg KA, Paltiel AD, Schackman BR. Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States. Ann Intern Med. 2013 Jan 15; 158(2):84-92.
    View in: PubMed
  19. Ganguli I, Collins JE, Reichmann WM, Losina E, Katz JN, Arbelaez C, Donnell-Fink LA, Walensky RP. Missed Opportunities: Refusal to Confirm Reactive Rapid HIV Tests in the Emergency Department. PLoS One. 2013; 8(1):e53408.
    View in: PubMed
  20. Donnell-Fink LA, Arbelaez C, Collins JE, Novais A, Case A, Pisculli ML, Reichmann WM, Katz JN, Losina E, Walensky RP. Acceptability of Fingerstick Versus Oral Fluid Rapid HIV Testing: Results From the Universal Screening for HIV Infection in the Emergency Room (USHER Phase II) Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2012 Dec 15; 61(5):588-92.
    View in: PubMed
  21. Ciaranello AL, Perez F, Engelsmann B, Walensky RP, Mushavi A, Rusibamayila A, Keatinge J, Park JE, Maruva M, Cerda R, Wood R, Dabis F, Freedberg KA. Cost-effectiveness of World Health Organization 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe. Clin Infect Dis. 2013 Feb; 56(3):430-46.
    View in: PubMed
  22. Paltiel AD, Walensky RP. Home HIV testing: good news but not a game changer. Ann Intern Med. 2012 Nov 20; 157(10):744-6.
    View in: PubMed
  23. Ramirez-Avila L, Regan S, Giddy J, Chetty S, Ross D, Katz JN, Freedberg KA, Walensky RP, Losina E, Bassett IV. Depressive Symptoms and Their Impact on Health-seeking Behaviors in Newly-diagnosed HIV-infected Patients in Durban, South Africa. AIDS Behav. 2012 Nov; 16(8):2226-35.
    View in: PubMed
  24. Shenoy ES, Hsu H, Noubary F, Hooper DC, Walensky RP. National Survey of Infection Preventionists: Policies for Discontinuation of Contact Precautions for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus. Infect Control Hosp Epidemiol. 2012 Dec; 33(12):1272-5.
    View in: PubMed
  25. Levison JH, Wood R, Scott CA, Ciaranello AL, Martinson NA, Rusu C, Losina E, Freedberg KA, Walensky RP. The Clinical and Economic Impact of Genotype Testing at First-line Antiretroviral Therapy Failure for HIV-Infected Patients in South Africa. Clin Infect Dis. 2013 Feb; 56(4):587-97.
    View in: PubMed
  26. Bogart LM, Chetty S, Giddy J, Sypek A, Sticklor L, Walensky RP, Losina E, Katz JN, Bassett IV. Barriers to care among people living with HIV in South Africa: Contrasts between patient and healthcare provider perspectives. AIDS Care. 2013 Jul; 25(7):843-53.
    View in: PubMed
  27. Ramirez-Avila L, Nixon K, Noubary F, Giddy J, Losina E, Walensky RP, Bassett IV. Routine HIV testing in adolescents and young adults presenting to an outpatient clinic in Durban, South Africa. PLoS One. 2012; 7(9):e45507.
    View in: PubMed
  28. Schackman BR, Metsch LR, Colfax GN, Leff JA, Wong A, Scott CA, Feaster DJ, Gooden L, Matheson T, Haynes LF, Paltiel AD, Walensky RP. The cost-effectiveness of rapid HIV testing in substance abuse treatment: Results of a randomized trial. Drug Alcohol Depend. 2013 Feb 1; 128(1-2):90-7.
    View in: PubMed
  29. Hom JK, Wang B, Chetty S, Giddy J, Mazibuko M, Allen J, Walensky RP, Losina E, Freedberg KA, Bassett IV. Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa. PLoS One. 2012; 7(8):e43281.
    View in: PubMed
  30. Anglaret X, Scott CA, Walensky RP, Ouattara E, Losina E, Moh R, Becker JE, Uhler L, Danel C, Messou E, Eholié S, Freedberg KA. Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis. Antivir Ther. 2013; 18(1):45-55.
    View in: PubMed
  31. Shenoy ES, Walensky RP, Lee H, Orcutt B, Hooper DC. Resource burden associated with contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: the patient access managers' perspective. Infect Control Hosp Epidemiol. 2012 Aug; 33(8):849-52.
    View in: PubMed
  32. Andrews JR, Wood R, Bekker LG, Middelkoop K, Walensky RP. Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care. J Infect Dis. 2012 Aug 15; 206(4):543-51.
    View in: PubMed
  33. Lorenzana SB, Hughes MD, Grinsztejn B, Collier AC, Luz PM, Freedberg KA, Wood R, Levison JH, Mugyenyi PN, Salata R, Wallis CL, Weinstein MC, Schooley RT, Walensky RP. Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial. AIDS. 2012 Jun 1; 26(9):1083-93.
    View in: PubMed
  34. Andrews JR, Lawn SD, Rusu C, Wood R, Noubary F, Bender MA, Horsburgh CR, Losina E, Freedberg KA, Walensky RP. The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis. AIDS. 2012 May 15; 26(8):987-95.
    View in: PubMed
  35. Pho MT, Swaminathan S, Kumarasamy N, Losina E, Ponnuraja C, Uhler LM, Scott CA, Mayer KH, Freedberg KA, Walensky RP. The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis. PLoS One. 2012; 7(4):e36001.
    View in: PubMed
  36. Metsch LR, Feaster DJ, Gooden L, Matheson T, Mandler RN, Haynes L, Tross S, Kyle T, Gallup D, Kosinski AS, Douaihy A, Schackman BR, Das M, Lindblad R, Erickson S, Korthuis PT, Martino S, Sorensen JL, Szapocznik J, Walensky R, Branson B, Colfax GN. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012 Jun; 102(6):1160-7.
    View in: PubMed
  37. Tucker JD, Walensky RP, Yang LG, Yang B, Bangsberg DR, Chen XS, Cohen MS. Expanding provider-initiated HIV testing at STI clinics in China. AIDS Care. 2012; 24(10):1316-9.
    View in: PubMed
  38. Walensky RP, Park JE, Wood R, Freedberg KA, Scott CA, Bekker LG, Losina E, Mayer KH, Seage GR, Paltiel AD. The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. Clin Infect Dis. 2012 May; 54(10):1504-13.
    View in: PubMed
  39. Yazdanpanah Y, Walensky RP, Rozenbaum W, Yeni P, Paltiel AD. What is a modest public health impact? Arch Intern Med. 2012 Mar 26; 172(6):521-2; author reply 522-3.
    View in: PubMed
  40. Ouattara EN, Anglaret X, Wong AY, Chu J, Hsu HE, Danel C, Eholié S, Moh R, Gabillard D, Walensky RP, Freedberg KA. Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age. AIDS. 2012 Mar 13; 26(5):625-34.
    View in: PubMed
  41. Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, Horsburgh CR. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis. 2012 Mar; 54(6):784-91.
    View in: PubMed
  42. O'Hagan JJ, Hernán MA, Walensky RP, Lipsitch M. Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials. AIDS. 2012 Jan 14; 26(2):123-6.
    View in: PubMed
  43. Ciaranello AL, Perez F, Keatinge J, Park JE, Engelsmann B, Maruva M, Walensky RP, Dabis F, Chu J, Rusibamayila A, Mushavi A, Freedberg KA. What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis. PLoS Med. 2012 Jan; 9(1):e1001156.
    View in: PubMed
  44. Sloan CE, Champenois K, Choisy P, Losina E, Walensky RP, Schackman BR, Ajana F, Melliez H, Paltiel AD, Freedberg KA, Yazdanpanah Y. Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults. AIDS. 2012 Jan 2; 26(1):45-56.
    View in: PubMed
  45. Bassett IV, Chetty S, Wang B, Mazibuko M, Giddy J, Lu Z, Walensky RP, Freedberg KA, Losina E. Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa. J Acquir Immune Defic Syndr. 2012 Jan 1; 59(1):25-30.
    View in: PubMed
  46. Reichmann WM, Walensky RP, Case A, Novais A, Arbelaez C, Katz JN, Losina E. Estimation of the prevalence of undiagnosed and diagnosed HIV in an urban emergency department. PLoS One. 2011; 6(11):e27701.
    View in: PubMed
  47. Kerry VB, Ndung'u T, Walensky RP, Lee PT, Kayanja VF, Bangsberg DR. Managing the demand for global health education. PLoS Med. 2011 Nov; 8(11):e1001118.
    View in: PubMed
  48. Walensky RP, Morris BL, Reichmann WM, Paltiel AD, Arbelaez C, Donnell-Fink L, Katz JN, Losina E. Resource utilization and cost-effectiveness of counselor- vs. provider-based rapid point-of-care HIV screening in the emergency department. PLoS One. 2011; 6(10):e25575.
    View in: PubMed
  49. Walensky RP, Bassett IV. HIV self-testing and the missing linkage. PLoS Med. 2011 Oct; 8(10):e1001101.
    View in: PubMed
  50. Walensky RP, Reichmann WM, Arbelaez C, Wright E, Katz JN, Seage GR, Safren SA, Hare AQ, Novais A, Losina E. Counselor- versus provider-based HIV screening in the emergency department: results from the universal screening for HIV infection in the emergency room (USHER) randomized controlled trial. Ann Emerg Med. 2011 Jul; 58(1 Suppl 1):S126-32.e1-4.
    View in: PubMed
  51. Hsu H, Walensky RP. Cost-effectiveness analysis and HIV screening: the emergency medicine perspective. Ann Emerg Med. 2011 Jul; 58(1 Suppl 1):S145-50.
    View in: PubMed
  52. Donnell-Fink L, Reichmann WM, Arbelaez C, Case AL, Katz JN, Losina E, Walensky RP. Patient satisfaction with rapid HIV testing in the emergency department. Ann Emerg Med. 2011 Jul; 58(1 Suppl 1):S49-52.
    View in: PubMed
  53. Ciaranello AL, Perez F, Maruva M, Chu J, Engelsmann B, Keatinge J, Walensky RP, Mushavi A, Mugwagwa R, Dabis F, Freedberg KA. WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers. PLoS One. 2011; 6(6):e20224.
    View in: PubMed
  54. Ciaranello AL, Park JE, Ramirez-Avila L, Freedberg KA, Walensky RP, Leroy V. Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions. BMC Med. 2011; 9:59.
    View in: PubMed
  55. Pisculli ML, Reichmann WM, Losina E, Donnell-Fink LA, Arbelaez C, Katz JN, Walensky RP. Factors associated with refusal of rapid HIV testing in an emergency department. AIDS Behav. 2011 May; 15(4):734-42.
    View in: PubMed
  56. Wang B, Losina E, Stark R, Munro A, Walensky RP, Wilke M, Martin D, Lu Z, Freedberg KA, Wood R. Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 count. S Afr Med J. 2011 Apr; 101(4):253-7.
    View in: PubMed
  57. Ciaranello AL, Lockman S, Freedberg KA, Hughes M, Chu J, Currier J, Wood R, Holmes CB, Pillay S, Conradie F, McIntyre J, Losina E, Walensky RP. First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial. AIDS. 2011 Feb 20; 25(4):479-92.
    View in: PubMed
  58. Losina E, Walensky RP, Reichmann WM, Holt HL, Gerlovin H, Solomon DH, Jordan JM, Hunter DJ, Suter LG, Weinstein AM, Paltiel AD, Katz JN. Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans. Ann Intern Med. 2011 Feb 15; 154(4):217-26.
    View in: PubMed
  59. Hsu HE, Rydzak CE, Cotich KL, Wang B, Sax PE, Losina E, Freedberg KA, Goldie SJ, Lu Z, Walensky RP. Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA. HIV Med. 2011 Feb; 12(2):97-108.
    View in: PubMed
  60. April MD, Chiosi JJ, Paltiel AD, Sax PE, Walensky RP. Projected survival gains from revising state laws requiring written opt-in consent for HIV testing. J Gen Intern Med. 2011 Jun; 26(6):661-7.
    View in: PubMed
  61. Walensky RP, Wood R, Fofana MO, Martinson NA, Losina E, April MD, Bassett IV, Morris BL, Freedberg KA, Paltiel AD. The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa. J Acquir Immune Defic Syndr. 2011 Jan; 56(1):26-35.
    View in: PubMed
  62. Bassett IV, Chetty S, Giddy J, Reddy S, Bishop K, Lu Z, Losina E, Freedberg KA, Walensky RP. Screening for acute HIV infection in South Africa: finding acute and chronic disease. HIV Med. 2011 Jan; 12(1):46-53.
    View in: PubMed
  63. Walensky RP, Wood R, Ciaranello AL, Paltiel AD, Lorenzana SB, Anglaret X, Stoler AW, Freedberg KA. Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis. PLoS Med. 2010; 7(12):e1000382.
    View in: PubMed
  64. Martin EG, Paltiel AD, Walensky RP, Schackman BR. Expanded HIV screening in the United States: what will it cost government discretionary and entitlement programs? A budget impact analysis. Value Health. 2010 Dec; 13(8):893-902.
    View in: PubMed
  65. Yazdanpanah Y, Sloan CE, Charlois-Ou C, Le Vu S, Semaille C, Costagliola D, Pillonel J, Poullié AI, Scemama O, Deuffic-Burban S, Losina E, Walensky RP, Freedberg KA, Paltiel AD. Routine HIV screening in France: clinical impact and cost-effectiveness. PLoS One. 2010; 5(10):e13132.
    View in: PubMed
  66. Bassett IV, Wang B, Chetty S, Giddy J, Losina E, Mazibuko M, Bearnot B, Allen J, Walensky RP, Freedberg KA. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis. 2010 Oct 1; 51(7):823-9.
    View in: PubMed
  67. Uhler LM, Kumarasamy N, Mayer KH, Saxena A, Losina E, Muniyandi M, Stoler AW, Lu Z, Walensky RP, Flanigan TP, Bender MA, Freedberg KA, Swaminathan S. Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India. PLoS One. 2010; 5(9).
    View in: PubMed
  68. Walensky RP, Paltiel AD, Losina E, Morris BL, Scott CA, Rhode ER, Seage GR, Freedberg KA. Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Infect Dis. 2010 Aug 15; 51(4):392-400.
    View in: PubMed
  69. Walensky RP, Ciaranello AL, Park JE, Freedberg KA. Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature. Clin Infect Dis. 2010 Jul 1; 51(1):85-92.
    View in: PubMed
  70. Kimmel AD, Weinstein MC, Anglaret X, Goldie SJ, Losina E, Yazdanpanah Y, Messou E, Cotich KL, Walensky RP, Freedberg KA. Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness. J Acquir Immune Defic Syndr. 2010 Jul; 54(3):258-68.
    View in: PubMed
  71. Linas BP, Wang B, Smurzynski M, Losina E, Bosch RJ, Schackman BR, Rong J, Sax PE, Walensky RP, Schouten J, Freedberg KA. The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort. J Viral Hepat. 2011 Jul; 18(7):506-12.
    View in: PubMed
  72. Bassett IV, Walensky RP. Integrating HIV screening into routine health care in resource-limited settings. Clin Infect Dis. 2010 May 15; 50 Suppl 3:S77-84.
    View in: PubMed
  73. Walensky RP. A piece of my mind. Disclosure. JAMA. 2010 May 5; 303(17):1676-7.
    View in: PubMed
  74. Losina E, Bassett IV, Giddy J, Chetty S, Regan S, Walensky RP, Ross D, Scott CA, Uhler LM, Katz JN, Holst H, Freedberg KA. The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One. 2010; 5(3):e9538.
    View in: PubMed
  75. Williams-Roberts H, Chang Y, Losina E, Freedberg KA, Walensky RP. Frequent HIV testing among participants of a routine HIV testing program. Virulence. 2010 Mar-Apr; 1(2):68-71.
    View in: PubMed
  76. Bender MA, Kumarasamy N, Mayer KH, Wang B, Walensky RP, Flanigan T, Schackman BR, Scott CA, Lu Z, Freedberg KA. Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India. Clin Infect Dis. 2010 Feb 1; 50(3):416-25.
    View in: PubMed
  77. Walensky RP, Kuritzkes DR. The impact of the President's Emergency Plan for AIDS Relief (PEPfAR) beyond HIV and why it remains essential. Clin Infect Dis. 2010 Jan 15; 50(2):272-5.
    View in: PubMed
  78. Reichmann WM, Losina E, Seage GR, Arbelaez C, Safren SA, Katz JN, Hetland A, Walensky RP. Does modality of survey administration impact data quality: audio computer assisted self interview (ACASI) versus self-administered pen and paper? PLoS One. 2010; 5(1):e8728.
    View in: PubMed
  79. Yazdanpanah Y, Wolf LL, Anglaret X, Gabillard D, Walensky RP, Moh R, Danel C, Sloan CE, Losina E, Freedberg KA. CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials. Antivir Ther. 2010; 15(3):351-61.
    View in: PubMed
  80. Mimiaga MJ, Reichmann WM, Safren SA, Losina E, Arbelaez C, Walensky RP. Prevalence and correlates of clinically significant depressive symptoms in an urban hospital emergency department. Prim Care Companion J Clin Psychiatry. 2010; 12(2).
    View in: PubMed
  81. Bassett IV, Regan S, Chetty S, Giddy J, Uhler LM, Holst H, Ross D, Katz JN, Walensky RP, Freedberg KA, Losina E. Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should. AIDS. 2010 Jan; 24 Suppl 1:S37-44.
    View in: PubMed
  82. Ciaranello AL, Chang Y, Margulis AV, Bernstein A, Bassett IV, Losina E, Walensky RP. Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis. 2009 Dec 15; 49(12):1915-27.
    View in: PubMed
  83. Losina E, Schackman BR, Sadownik SN, Gebo KA, Walensky RP, Chiosi JJ, Weinstein MC, Hicks PL, Aaronson WH, Moore RD, Paltiel AD, Freedberg KA. Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis. 2009 Nov 15; 49(10):1570-8.
    View in: PubMed
  84. Ganguli I, Bassett IV, Dong KL, Walensky RP. Home testing for HIV infection in resource-limited settings. Curr HIV/AIDS Rep. 2009 Nov; 6(4):217-23.
    View in: PubMed
  85. Losina E, Touré H, Uhler LM, Anglaret X, Paltiel AD, Balestre E, Walensky RP, Messou E, Weinstein MC, Dabis F, Freedberg KA. Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal. PLoS Med. 2009 Oct; 6(10):e1000173.
    View in: PubMed
  86. Arbelaez C, Wright EA, Losina E, Millen JC, Kimmel S, Dooley M, Reichmann WM, Mikulinsky R, Walensky RP. Emergency provider attitudes and barriers to universal HIV testing in the emergency department. J Emerg Med. 2012 Jan; 42(1):7-14.
    View in: PubMed
  87. Walensky RP. Cost-effectiveness of HIV interventions: from cohort studies and clinical trials to policy. Top HIV Med. 2009 Sep-Oct; 17(4):130-4.
    View in: PubMed
  88. Arbelaez C, Block B, Losina E, Wright EA, Reichmann WM, Mikulinsky R, Solomon JD, Dooley MM, Walensky RP. Rapid HIV testing program implementation: lessons from the emergency department. Int J Emerg Med. 2009; 2(3):187-94.
    View in: PubMed
  89. Linas BP, Losina E, Rockwell A, Walensky RP, Cranston K, Freedberg KA. Improving outcomes in state AIDS drug assistance programs. J Acquir Immune Defic Syndr. 2009 Aug 15; 51(5):513-21.
    View in: PubMed
  90. Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E. When to start antiretroviral therapy in resource-limited settings. Ann Intern Med. 2009 Aug 4; 151(3):157-66.
    View in: PubMed
  91. April MD, Walensky RP, Chang Y, Pitt J, Freedberg KA, Losina E, Paltiel AD, Wood R. HIV testing rates and outcomes in a South African community, 2001-2006: implications for expanded screening policies. J Acquir Immune Defic Syndr. 2009 Jul 1; 51(3):310-6.
    View in: PubMed
  92. Losina E, Walensky RP, Kessler CL, Emrani PS, Reichmann WM, Wright EA, Holt HL, Solomon DH, Yelin E, Paltiel AD, Katz JN. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. Arch Intern Med. 2009 Jun 22; 169(12):1113-21; discussion 1121-2.
    View in: PubMed
  93. Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, Giddy J, Lu Z, Losina E, Walensky RP, Freedberg KA. Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr. 2009 Jun 1; 51(2):135-9.
    View in: PubMed
  94. Paltiel AD, Freedberg KA, Scott CA, Schackman BR, Losina E, Wang B, Seage GR, Sloan CE, Sax PE, Walensky RP. HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clin Infect Dis. 2009 Mar 15; 48(6):806-15.
    View in: PubMed
  95. Orrell C, Walensky RP, Losina E, Pitt J, Freedberg KA, Wood R. HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme. Antivir Ther. 2009; 14(4):523-31.
    View in: PubMed
  96. Ciaranello AL, Walensky RP, Sax PE, Chang Y, Freedberg KA, Weissman JS. Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents. HIV Clin Trials. 2009 Jan-Feb; 10(1):13-24.
    View in: PubMed
  97. Lyons MS, Lindsell CJ, Haukoos JS, Almond G, Brown J, Calderon Y, Couture E, Merchant RC, White DA, Rothman RE, Aldridge C, Almond G, Andrade G, Arbelaez C, Archinard TM, Aronin SI, Barrera S, Bateganya M, Bell-Merriam J, Bongiovanni B, Brady K, Branson B, Brosgart C, Brown J, Cadoff E, Calderon Y, Chaille-Arnold L, Cheng B, Chiang W, Copeland B, Cousar RL, Couture E, Czarnogorski M, Delgado K, Erbelding E, Feldman J, Garcia O, Gaydos CA, Glick N, Gripshover B, Haukoos J, Hayes A, Heffelfinger J, Herrera L, Hilley A, Holtgrave D, Hoots B, Hopkins E, Houry D, Howell D, Hsieh YH, Hutchinson AB, Jackson B, Jaker M, Jones K, Jung J, Kampe L, Kan V, Kass N, Kelen GD, Kroc K, Kurth A, Lampe MA, Leider J, Lemanski M, Lindsell CJ, Lyons M, McGovern S, Mercer S, Merchant R, Miertschin N, Miller J, Mitchell P, Nelson S, Onaga L, Paltiel D, Paul S, Pollack H, Raffanti S, Randall L, Rothman R, Sabreen A, Sankoff J, Sasso V, Saylor NB, Schechter E, Schechtman B, Schrantz S, Scribner A, Shahan J, Skiest D, Spielberg F, Stennett IS, Sullivan P, Teahan C, Thompson S, Torres G, Totten V, Wagner K, Walensky R, Waxman M, Weddle A, White D, Widell T, Wilde JA, Wrenn K, Yonek J. Nomenclature and definitions for emergency department human immunodeficiency virus (HIV) testing: report from the 2007 conference of the National Emergency Department HIV Testing Consortium. Acad Emerg Med. 2009 Feb; 16(2):168-77.
    View in: PubMed
  98. Ciaranello AL, Seage GR, Freedberg KA, Weinstein MC, Lockman S, Walensky RP. Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity. AIDS. 2008 Nov 12; 22(17):2359-69.
    View in: PubMed
  99. Asmal M, Factor RE, Walensky RP. Photo quiz. An HIV-infected man with an upset stomach. Clin Infect Dis. 2008 Oct 1; 47(7):935-6; 979-80.
    View in: PubMed
  100. Schackman BR, Scott CA, Walensky RP, Losina E, Freedberg KA, Sax PE. The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV. AIDS. 2008 Oct 1; 22(15):2025-33.
    View in: PubMed
  101. Bassett IV, Farel C, Szmuilowicz ED, Walensky RP. HIV/AIDS: AIDS Drug Assistance Programs in the era of routine HIV testing. Clin Infect Dis. 2008 Sep 1; 47(5):695-701.
    View in: PubMed
  102. Jean-Jacques M, Walensky RP, Aaronson WH, Chang Y, Freedberg KA. Late diagnosis of HIV infection at two academic medical centers: 1994-2004. AIDS Care. 2008 Sep; 20(8):977-83.
    View in: PubMed
  103. Bassett IV, Giddy J, Wang B, Lu Z, Losina E, Freedberg KA, Walensky RP. Routine, voluntary HIV testing in Durban, South Africa: correlates of HIV infection. HIV Med. 2008 Nov; 9(10):863-7.
    View in: PubMed
  104. Walensky RP, Arbelaez C, Reichmann WM, Walls RM, Katz JN, Block BL, Dooley M, Hetland A, Kimmel S, Solomon JD, Losina E. Revising expectations from rapid HIV tests in the emergency department. Ann Intern Med. 2008 Aug 5; 149(3):153-60.
    View in: PubMed
  105. Walensky RP, Freedberg KA, Weinstein MC. Monitoring of antiretroviral therapy in low-resource settings. Lancet. 2008 Jul 26; 372(9635):288; author reply 289.
    View in: PubMed
  106. Millen JC, Arbelaez C, Walensky RP. Implications and impact of the new US Centers for Disease Control and prevention HIV testing guidelines. Curr Infect Dis Rep. 2008 May; 10(2):157-63.
    View in: PubMed
  107. Walensky RP, Wood R, Weinstein MC, Martinson NA, Losina E, Fofana MO, Goldie SJ, Divi N, Yazdanpanah Y, Wang B, Paltiel AD, Freedberg KA. Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. J Infect Dis. 2008 May 1; 197(9):1324-32.
    View in: PubMed
  108. Waisbren SE, Bowles H, Hasan T, Zou KH, Emans SJ, Goldberg C, Gould S, Levine D, Lieberman E, Loeken M, Longtine J, Nadelson C, Patenaude AF, Quinn D, Randolph AG, Solet JM, Ullrich N, Walensky R, Weitzman P, Christou H. Gender differences in research grant applications and funding outcomes for medical school faculty. J Womens Health (Larchmt). 2008 Mar; 17(2):207-14.
    View in: PubMed
  109. Ojikutu BO, Zheng H, Walensky RP, Lu Z, Losina E, Giddy J, Freedberg KA. Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. S Afr Med J. 2008 Mar; 98(3):204-8.
    View in: PubMed
  110. Walensky RP, Freedberg KA, Weinstein MC, Paltiel AD. Cost-effectiveness of HIV testing and treatment in the United States. Clin Infect Dis. 2007 Dec 15; 45 Suppl 4:S248-54.
    View in: PubMed
  111. Yazdanpanah Y, Vray M, Meynard J, Losina E, Weinstein MC, Morand-Joubert L, Goldie SJ, Hsu HE, Walensky RP, Dalban C, Sax PE, Girard PM, Freedberg KA. The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach. HIV Med. 2007 Oct; 8(7):439-50.
    View in: PubMed
  112. Bassett IV, Giddy J, Nkera J, Wang B, Losina E, Lu Z, Freedberg KA, Walensky RP. Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department. J Acquir Immune Defic Syndr. 2007 Oct 1; 46(2):181-6.
    View in: PubMed
  113. Freedberg KA, Kumarasamy N, Losina E, Cecelia AJ, Scott CA, Divi N, Flanigan TP, Lu Z, Weinstein MC, Wang B, Ganesh AK, Bender MA, Mayer KH, Walensky RP. Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy. AIDS. 2007 Jul; 21 Suppl 4:S117-28.
    View in: PubMed
  114. Walensky RP, Weinstein MC, Yazdanpanah Y, Losina E, Mercincavage LM, Touré S, Divi N, Anglaret X, Goldie SJ, Freedberg KA. HIV drug resistance surveillance for prioritizing treatment in resource-limited settings. AIDS. 2007 May 11; 21(8):973-82.
    View in: PubMed
  115. McCormick AW, Walensky RP, Lipsitch M, Losina E, Hsu H, Weinstein MC, Paltiel AD, Freedberg KA, Seage GR. The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men. Clin Infect Dis. 2007 Apr 15; 44(8):1115-22.
    View in: PubMed
  116. Losina E, Walensky RP, Geller A, Beddingfield FC, Wolf LL, Gilchrest BA, Freedberg KA. Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol. 2007 Jan; 143(1):21-8.
    View in: PubMed
  117. Wolf LL, Walensky RP. Testing for HIV infection in the United States. Curr Infect Dis Rep. 2007 Jan; 9(1):76-82.
    View in: PubMed
  118. Cha JH, Furie K, Kay J, Walensky RP, Mullins ME, Hedley-Whyte ET. Case records of the Massachusetts General Hospital. Case 39-2006. A 24-year-old woman with systemic lupus erythematosus, seizures, and right arm weakness. N Engl J Med. 2006 Dec 21; 355(25):2678-89.
    View in: PubMed
  119. Paltiel AD, Walensky RP, Schackman BR, Seage GR, Mercincavage LM, Weinstein MC, Freedberg KA. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med. 2006 Dec 5; 145(11):797-806.
    View in: PubMed
  120. Walensky RP. APTIMA assay approved for HIV testing. AIDS Clin Care. 2006 Dec; 18(12):109-10.
    View in: PubMed
  121. Ciaranello AL, Olans R, Walensky RP. Vesiculopapular rash. Clin Infect Dis. 2006 Nov 15; 43(10):1308, 1368-9.
    View in: PubMed
  122. Liddicoat RV, Zheng H, Internicola J, Werner BG, Kazianis A, Golan Y, Rubinstein EP, Freedberg KA, Walensky RP. Implementing a routine, voluntary HIV testing program in a Massachusetts county prison. J Urban Health. 2006 Nov; 83(6):1127-31.
    View in: PubMed
  123. Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage GR, Moore RD, Freedberg KA. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care. 2006 Nov; 44(11):990-7.
    View in: PubMed
  124. Linas BP, Zheng H, Losina E, Rockwell A, Walensky RP, Cranston K, Freedberg KA. Optimizing resource allocation in United States AIDS drug assistance programs. Clin Infect Dis. 2006 Nov 15; 43(10):1357-64.
    View in: PubMed
  125. Walensky RP, Paltiel AD. Rapid HIV testing at home: does it solve a problem or create one? Ann Intern Med. 2006 Sep 19; 145(6):459-62.
    View in: PubMed
  126. Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, Hsu HE, Kimmel A, Holmes C, Kaplan JE, Freedberg KA. Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire. N Engl J Med. 2006 Sep 14; 355(11):1141-53.
    View in: PubMed
  127. Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006 Jul 1; 194(1):11-9.
    View in: PubMed
  128. Losina E, Anglaret X, Yazdanpanah Y, Wang B, Toure S, Seage GR, N'Dri-Yoman T, Walensky RP, Dakoury-Dogbo N, Goldie SJ, Messou E, Weinstein MC, Deuffic-Burban S, Salamon R, Freedberg KA. Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire. S Afr Med J. 2006 Jun; 96(6):526-9.
    View in: PubMed
  129. Holmes CB, Zheng H, Martinson NA, Freedberg KA, Walensky RP. Optimizing treatment for HIV-infected South African women exposed to single-dose nevirapine: balancing efficacy and cost. Clin Infect Dis. 2006 Jun 15; 42(12):1772-80.
    View in: PubMed
  130. Linas BP, Zheng H, Losina E, Walensky RP, Freedberg KA. Assessing the impact of federal HIV prevention spending on HIV testing and awareness. Am J Public Health. 2006 Jun; 96(6):1038-43.
    View in: PubMed
  131. Cohen T, Lipsitch M, Walensky RP, Murray M. Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations. Proc Natl Acad Sci U S A. 2006 May 2; 103(18):7042-7.
    View in: PubMed
  132. Wertheimer BZ, Freedberg KA, Walensky RP, Yazdanapah Y, Losina E. Therapeutic drug monitoring in HIV treatment: a literature review. HIV Clin Trials. 2006 Mar-Apr; 7(2):59-69.
    View in: PubMed
  133. Liddicoat RV, Losina E, Kang M, Freedberg KA, Walensky RP. Refusing HIV testing in an urgent care setting: results from the "Think HIV" program. AIDS Patient Care STDS. 2006 Feb; 20(2):84-92.
    View in: PubMed
  134. Sax PE, Islam R, Walensky RP, Losina E, Weinstein MC, Goldie SJ, Sadownik SN, Freedberg KA. Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis. Clin Infect Dis. 2005 Nov 1; 41(9):1316-23.
    View in: PubMed
  135. Yazdanpanah Y, Losina E, Anglaret X, Goldie SJ, Walensky RP, Weinstein MC, Toure S, Smith HE, Kaplan JE, Freedberg KA. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis. AIDS. 2005 Aug 12; 19(12):1299-308.
    View in: PubMed
  136. Sax PE, Losina E, Weinstein MC, Paltiel AD, Goldie SJ, Muccio TM, Kimmel AD, Zhang H, Freedberg KA, Walensky RP. Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease. J Acquir Immune Defic Syndr. 2005 May 1; 39(1):69-77.
    View in: PubMed
  137. Walensky RP, Weinstein MC, Smith HE, Freedberg KA, Paltiel AD. Optimal allocation of testing dollars: the example of HIV counseling, testing, and referral. Med Decis Making. 2005 May-Jun; 25(3):321-9.
    View in: PubMed
  138. Walensky RP, Weinstein MC, Kimmel AD, Seage GR, Losina E, Sax PE, Zhang H, Smith HE, Freedberg KA, Paltiel AD. Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am J Med. 2005 Mar; 118(3):292-300.
    View in: PubMed
  139. Paltiel AD, Weinstein MC, Kimmel AD, Seage GR, Losina E, Zhang H, Freedberg KA, Walensky RP. Expanded screening for HIV in the United States--an analysis of cost-effectiveness. N Engl J Med. 2005 Feb 10; 352(6):586-95.
    View in: PubMed
  140. Liddicoat RV, Zheng H, Golan Y, Internicola J, Rubinstein EP, Freedberg KA, Walensky RP. The high acceptance rate of routine, voluntary HIV testing in a Massachusetts prison. 28th Society for General Internal Medicine Annual Meeting. 2005; New Orleans, LA.
  141. Bassett IV, Giddy J, Nkera J, Zheng H, Lu Z, Freedberg KA, Walensky RP. The yield of routine HIV testing in an outpatient department in Durban, South Africa. 2nd South African AIDS Conference. 2005; Durban, South Africa.
  142. Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA. Three million years of life saved: the survival benefits of AIDS therapy in the United States. Late breaker, Oral presentation, Society for Medical Decision Making. 2005; San Francisco, CA.
  143. Walensky RP, Losina E, Malatesta L, Barton GE, O'Connor CA, Skolnik PR, Hall JM, McGuire JF, Freedberg KA. Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts. Am J Public Health. 2005 Jan; 95(1):71-3.
    View in: PubMed
  144. Linas BP, Zheng H, Losina H, Walensky RP, Freedberg KA. Assessing the impact of CDC HIV prevention funding of HIV testing and knowledge. 28th Society for General Internal Medicine Annual Meeting. 2005; New Orleans, LA.
  145. Paltiel AD, Weinstein MC, Kimmel AD, Seage GR, Losina E, Zhang H, Freedberg KA, Walensky RP. Expanded HIV screening in the United States - A cost-effectiveness analysis. N Eng J Med. 2005; 352:586-95.
  146. Kimmel AD, Goldie SJ, Walensky RP, Losina E, Weinstein MC, Paltiel AD, Zhang H, Freedberg KA. Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients. Antivir Ther. 2005; 10(1):41-52.
    View in: PubMed
  147. Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA. Two million years of life saved: the survival benefits of AIDS therapy in the United States. Late breaker, Oral presentation, 12th Conference of Retroviruses and Opportunistic Infections. 2005; Boston, MA.
  148. Bassett IV, Giddy J, Nkera J, Zheng H, Lu Z, Freedberg KA, Walensky RP. Missed HIV testing opportunities at a voluntary counseling and testing center in Durban, South Africa. Abstract 877. Infectious Diseases Society of America. 2005; San Francisco, CA.
  149. Sax PE, Losina E, Weinstein MC, Paltiel AD, Goldie SJ, Muccio TM, Kimmel AD, Zhang H, Freedberg KA, Walensky RP. Cost-effectiveness of enfuvirtide (ENF) in treatment-experienced patients with advanced HIV disease. JAIDS. 2005; 39:69-77.
  150. Walensky RP, Weinstein MC, Smith HE, Freedberg KA, Paltiel AD. Optimal allocation of testing dollars: the example of HIV counseling, testing, and referral. Medical Decision Making. 2005; 25:321-329.
  151. Walensky RP, Paltiel AD, Goldie SJ, Gandhi RT, Weinstein MC, Seage GR, Smith HE, Zhang H, Freedberg KA. A therapeutic HIV vaccine: how good is good enough? Vaccine. 2004 Sep 28; 22(29-30):4044-53.
    View in: PubMed
  152. Bassett IV, Freedberg KA, Walensky RP. Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV. Clin Infect Dis. 2004 Aug 1; 39(3):395-401.
    View in: PubMed
  153. Losina E, Islam R, Pollock AC, Sax PE, Freedberg KA, Walensky RP. Effectiveness of antiretroviral therapy after protease inhibitor failure: an analytic overview. Clin Infect Dis. 2004 Jun 1; 38(11):1613-22.
    View in: PubMed
  154. Walensky RP, Losina E, Skolnik PR, Hall JM, Malatesta L, Barton GE, O'Connor CA, McGuire JF, Freedberg, KA. Voluntary HIV testing as part of routine medical care, Massachusetts 2002. Morb Mort Wkly Rep. 2004; 53:523-26.
  155. Yazdanpanah Y, Losina E, Anglaret X, Goldie SJ, Walensky RP, Weinstein MC, Toure S, Smith HE, Kimmel AD, Zhang H, N'Dri-Yoman T, Salamon R, Kaplan K, Freedberg KA. Clinical impact and cost-effectivness of co-trimoxazole prophylaxis in patients living with HIV/AIDS in Cote d'Ivoire: a trial-based analysis. XV International AIDS Conference. 2004; Bangkok, Thailand.
  156. Losina E, Wolfe MI, Sax PE, Weinstein MC, Seage III GR, Goldie SJ, Walensky RP, Sullivan P, Paltiel AD, Kaplan J, Freedberg KA. Does highly active antiretroviral therapy (HAART) reduce rates of opportunistic infections (OIs) independent of CD4 cell count? Results from the Adolescent and Adult Spectrum of HIV Disease (ASD) Project. XV International AIDS Conference. 2004; Bangkok, Thailand.
  157. Liddicoat RV, Losina E, Kang M, Freedberg KA, Walensky RP. Missed Opportunities: Refusers of Routine HIV Testing in an Urgent Care Setting. 27th Society for General Internal Medicine Annual Meeting. 2004; Chicago, IL.
  158. Goldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage GR, Kimmel AD, Walensky RP, Sax PE, Freedberg KA. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med. 2003 Dec 1; 115(8):632-41.
    View in: PubMed
  159. Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KA. Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clin Infect Dis. 2003 Mar 1; 36(5):652-62.
    View in: PubMed
  160. Walensky RP, Weinstein MC, Kimmel AD, Seage GR, Losina E, Sax PE, Zhang H, Freedberg KA, Paltiel AD. Routine inpatient HIV testing: A clinical and economic evaluation of national guidelines. Oral Presentation, National HIV Prevention Conference. 2003; Atlanta, GA.
  161. Walensky RP, Weinstein MC, Kimmel AD, Seage GR, Losina E, Sax PE, Zhang H, Freedberg KA, Paltiel AD. A clinical and economic evaluation of CDC guidelines for routine inpatient HIV screening. Poster Presentation, 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. 2003; Paris, France.
  162. Paltiel AD, Weinstein MC, Kimmel AD, Seage GR, Losina E, Sax PE, Zhang H, Freedberg KA, Walensky RP. Clinical impact and cost-effectiveness of expanded HIV screening in the United States. Poster Presentation, 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. 2003; Paris, France.
  163. Sax PE, Losina E, Weinstein MC, Paltiel AD, Goldie SJ, Muccio TM, Kimmel AD, Zhang H, Freedberg KA, Walensky RP. Cost-effectiveness of a new fusion inhibitor (T-20) for patients who have failed antiretroviral therapy. Poster Presentation, 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. 2003; Paris, France.
  164. Kimmel AD, Goldie SJ, Walensky RP, Losina E, Weinstein MC, Paltiel AD, Zhang H, Freedberg KA. Optimal use of diagnostic tests prior to initiating antiretroviral therapy in HIV-infected patients. Oral Presentation, Society for Medical Decision Making. 2003; Chicago, IL.
  165. Walensky RP, Weinstein MC, Freedberg KA, Paltiel AD. Optimal allocation in sequential service processes: The example of HIV counseling, testing, and referral (HIVCTR). Oral Presentation, Society for Medical Decision Making. 2003; Chicago, IL.
  166. Losina E, Walensky RP, Gellar A, Beddingfield III F, Gilchrest B, Freedberg KA. Screening for malignant melanoma: clinical impact and cost-effectiveness. Oral Presentation, Society for Medical Decision Making. 2003; Chicago, IL.
  167. Losina E, Anglaret X, Yazdanpanah Y, Toure S, Seage GR, N'Dri-Yoman T, Walensky RP, Dakoury-Dogbo N, Goldie SJ, Messou KE, Weinstein MC, Salamon R, Freedberg KA. The impact of a history of opportunistic diseases on chronic HIV mortality in HIV patients in Cote d'Ivoire. Poster Presentation, 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. 2003; Paris, France.
  168. Walensky RP, Losina E, Malatesta L, Barton G, Maguire JF, Freedberg KA. The high yield of routine HIV screening in urgent care sites in Massachusetts. Oral Presentation, 10th Conference of Retroviruses and Opportunistic Infections. 2003; Boston, MA.
  169. Walensky RP, Goldie SJ, Sax PE, Weinstein MC, Paltiel AD, Kimmel AD, Seage GR, Losina E, Zhang H, Islam R, Freedberg KA. Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy. J Acquir Immune Defic Syndr. 2002 Sep 1; 31(1):27-37.
    View in: PubMed
  170. Walensky RP, Paltiel AD, Freedberg KA. AIDS Drug Assistance Programs: highlighting inequities in human immunodeficiency virus-infection health care in the United States. Clin Infect Dis. 2002 Sep 1; 35(5):606-10.
    View in: PubMed
  171. Walensky RP, Losina E, Steger-Craven KA, Freedberg KA. Identifying undiagnosed human immunodeficiency virus: the yield of routine, voluntary inpatient testing. Arch Intern Med. 2002 Apr 22; 162(8):887-92.
    View in: PubMed
  172. Losina E, Anglaret E, Yazdanpanah Y, Toure S, Pollock A, N'Dri-Yoman T, Walensky RP, Salamon R, Freedberg KA. Incidence of opportunistic infections (OIs) and mortality in HIV-infected patients in Ivory Coast. Poster Presentation, XIV International AIDS Conference. 2002; Barcelona, Spain.
  173. Vidrih JA, Walensky RP, Sax PE, Freedberg KA. Positive Epstein-Barr virus heterophile antibody tests in patients with primary human immunodeficiency virus infection. Am J Med. 2001 Aug 15; 111(3):192-4.
    View in: PubMed
  174. Walensky RP, Rosenberg ES, Ferraro MJ, Losina E, Walker BD, Freedberg KA. Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibody. Clin Infect Dis. 2001 Aug 15; 33(4):570-2.
    View in: PubMed
  175. Walensky RP, Moore R. A case series of 59 patients with nocardiosis: presentation and outcomes. Infect Dis Clin Pract. 2001; 10:249-54.
  176. Walensky RP, Hadigan CM, Freedberg KA, Lipsitch M. Impact of antiretroviral therapy on the HIV epidemic in Africa. Poster Presentation, Society for Medical Decision Making. 2001; San Diego, CA.
  177. Losina E, Weinstein MC, Goldie SJ, Paltiel AD, Seage GR, Walensky RP, Cohen CJ, Kimmel AK, Zhang H, Freedberg KA. Sources of variation in model-based life expectancy: portraying treatment efficacy in HIV disease. Poster Presentation, Society for Medical Decision Making. 2000; Cincinnati, OH.
  178. Kimmel AD, Goldie S, Paltiel AD, Losina E, Walensky RP, Weinstein MC, Zhang H, Seage GR, Cohen CJ, Craven DE, Freedberg KA. Optimal frequency of CD4 and HIV RNA testing in HIV-infected patients. Oral Presentation, Society for Medical Decision Making. 2000; Cincinnati, OH.
  179. Walensky RP, Goldberg JH, Daily JP. Anaphylaxis after rechallenge with abacavir. AIDS. 1999 May 28; 13(8):999-1000.
    View in: PubMed
  180. Walensky, RP, Hellmann DB. Case of the month. AM J Med. 1998; 105:544-5.
  181. Walensky RP, Venbrux AC, Prescott CA, Osterman FA. Pseudomyxoma peritonei. AJR Am J Roentgenol. 1996 Aug; 167(2):471-4.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Walensky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_